Search results
Novo Nordisk A/S (NYSE:NVO) Shares Acquired by Choreo LLC
ETF DAILY NEWS· 19 hours agoChoreo LLC increased its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 6.7% during the 4th quarter, according to its most recent filing ...
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Motley Fool via Yahoo Finance· 13 hours agoPerhaps the most well-known GLP-1 drugs are diabetes medication Ozempic and obesity care treatment...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 15 hours agoWeight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk. Both stocks...
Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
The Wall Street Journal· 1 day agoAmgen’s progress on its experimental weight-loss drug offered investors a reminder that Novo Nordisk...
Weight loss drug wins 25,000 new US users a week
BBC via Yahoo Finance· 2 days ago[Getty Images] Sign-ups for weight loss drug Wegovy jumped five-fold in the US in the first three months of the year, reaching a rate of more than 25,000...
Novo Nordisk To Slash Prices On Buzzy Drugs Ozempic and Wegovy
Futurism via Yahoo Finance· 1 day agoNovo Nordisk, the Danish maker of the injectable diabetes drug Ozempic and its sister weight-loss...
Wegovy maker Novo Nordisk extends losses following first-quarter results
CNBC· 2 days agoShares of Danish pharmaceutical giant Novo Nordisk slid 2.5% on Friday, extending a 2.7% loss on...
Should You Invest in Novo Nordisk (NVO) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 5 days agoNovo Nordisk's (NVO) revenues in the first quarter of 2024 are expected to have been driven by its...
Novo Nordisk Investing $6 Billion to Increase Access to Ozempic and Wegovy amid Nationwide Shortage
People Magazine· 2 days agoNovo Nordisk is investing $6.5 billion to increase production of Ozempic and Wegovy. The...
Novo Nordisk's Earnings Beat Estimates on Surging Demand for Its Weight-Loss Drugs
Investopedia· 3 days agoNovo Nordisk (NVO) reported first-quarter earnings Thursday that beat analysts' estimates as demand...